Cong Xu
Impact in
- Urology top 5%
- Urological Disorders and Treatments
- Urinary Bladder and Prostate Research
Papers in
- Oncology 9
- Cancer Cells and Metastasis 3
- HER2/EGFR in Cancer Research 2
- Neutropenia and Cancer Infections 2
-
- Ubiquitin and proteasome pathways 1
- Co-authors
- Tung‐Tien Sun (3 shared papers)Xiang‐Peng Kong (2 shared papers)Ge Zhou (2 shared papers)Roland Moll (2 shared papers)Feng‐Xia Liang (2 shared papers)Fang‐Ming Deng (2 shared papers)Hongyan Xiong (2 shared papers)Ning Mao (6 shared papers)
- Journals
- Infection and Drug Resistance (2 papers)Frontiers in Oncology (2 papers)Biochemical Journal (2 papers)PLoS ONE (1 paper)Pediatric Critical Care Medicine (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Cong Xu
43 papers receiving 921 citations
Cong Xu's Hit Papers
Peers
Comparison fields: 5 of 104
- Urology 91
- Health Informatics 9
- Cancer Research 82
- Oncology 136
- Radiology, Nuclear Medicine and Imaging 108
Countries citing papers authored by Cong Xu
This map shows the geographic impact of Cong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong Xu more than expected).
Fields of papers citing papers by Cong Xu
This network shows the impact of papers produced by Cong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong Xu. The network helps show where Cong Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Cong Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study Hit paper breakdown → | 2023 | 123 |
| 2 | 2001 | 89 | |
| 3 | Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway Hit paper breakdown → | 2024 | 83 |
| 4 | 2022 | 74 | |
| 5 | 2001 | 64 | |
| 6 | 2017 | 46 | |
| 7 | 1994 | 37 | |
| 8 | 2020 | 36 | |
| 9 | 2022 | 33 | |
| 10 | 2018 | 31 | |
| 11 | 2023 | 23 | |
| 12 | 2022 | 23 | |
| 13 | 2022 | 21 | |
| 14 | 2018 | 19 | |
| 15 | 2024 | 18 | |
| 16 | 2020 | 17 | |
| 17 | 2023 | 15 | |
| 18 | 2019 | 14 | |
| 19 | 2023 | 14 | |
| 20 | 2021 | 14 |
About Cong Xu
Cong Xu is a scholar working on Oncology, Molecular Biology, Surgery, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 45 papers that have together received 926 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (3 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (2 papers), HER2/EGFR in Cancer Research (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Neutropenia and Cancer Infections (2 papers), Occupational and environmental lung diseases (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Urology (91 citations), Health Informatics (9 citations), Cancer Research (82 citations), Oncology (136 citations) and Radiology, Nuclear Medicine and Imaging (108 citations). Cong Xu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Tung‐Tien Sun, Xiang‐Peng Kong, Ge Zhou, Roland Moll, Feng‐Xia Liang, Fang‐Ming Deng, Hongyan Xiong, Ning Mao, Kumar Ganesan and Jianping Chen. Their work appears in journals such as Infection and Drug Resistance, Frontiers in Oncology, Biochemical Journal, PLoS ONE and Pediatric Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.